A powerful encounter for diagnosing and treating heart disease along with utilization of echocardiography in the upcoming years, research was announced at the American Society of Echocardiography (ASE) 21st annual scientific sessions, where researchers revealed their findings.
The event which is held at San Diego Convention Center runs for four days. In attendance are 2,300 of the worlds top researchers in cardiovascular medicine and echocardiography.
One impressive study involves a non invasive ultrasound approach that can reveal symptoms of early heart muscle damage in breast cancer patients receiving chemotherapy.
In a lot of patients, the cancer is not what ultimately ended their life but the reactions from chemotherapy treatments. Dr. Heloisa Sawaya of Massachusetts General Hospital and Harvard Medical School stated the results will help oncologists in their assessments of heart muscle damage generated by chemotherapy after treatments of three months. This aides them to more effectively aide patients in assessing the treatment choices available, possibly lessening the occurrence of cardiotoxicity and its related foreboding death.
Researchers observed that with the increase of breast cancer survival cardiotoxicity or heart muscle damage is developing into a greater severe problem, as it can lead to death.
Researchers located two factors, cardiac troponin plasma concentrations and heart ultrasound measured peak longitudinal strain, are greater acute factors to deciding frequency of cardiotoxcicity. Forty three breast cancer patients were studied, conclusions revealed that the patients who had a decline in the heart ultrasound measured peak longitudinal strain of greater than ten percent from their baseline, or who displayed an increase cardiac troponin after undergoing three months of chemotherapy, displayed a nine fold increase in the risk of cardiotoxcicity at six months.
Another impressive study revealed at the sessions summarized findings that will aide heart value surgical prospects to improve predictions of their chance of dying after surgery. Researchers found that common models used for prediction of heart valve surgery death are established upon clinical preoperative chance factors and examination of left ventricular function. Right ventricular outlines are not included in the assessment. Researchers evaluated the preoperative echocardiograms of 258 patients and discovered RV outlines to be sole predictors of long term death.
These conclusions will aide families, caregivers and patients to make informed choices about the suitable timing for heart surgery. Dr. Venkatesh Y. Anjan of Northwestern’s University Feinberg School of Medicine, head researcher of the study stated observing the correct heart using an echocardiogram or ultrasound gives extra knowledge, allowing a better comprehensive evaluation of the risk linked with performing mitral valve surgery.
One of the leading conventional treatments for cancer is chemotherapy. However, a lot of persons who have had the treatment state that it also destroys your body. One downfall of chemotherapy is even though it does destroy the cancer cells it can not distinguish between the cancerous ones and the healthy ones.
There are alternative therapies that are available. These treatments are in the testing stages so no real evidence of their effectiveness has yet been established. They are showing great promise as an alternative to chemotherapy treatments. Current indications reveal that up to 64% of cancer patients use alternative treatments. Below are a few that are available.
IPT treatments is a low dose chemotherapy treatment which has been changed to give the patient a more friendlier and gentler treatment lessening the adverse shock of conventional chemotherapy. The insulin applied allows the physician to guide all the chemotherapeutic agents to the cancer cells only. The healthy cells are not affected. Only 10% of the conventional chemotherapy drug is used. Due to this small amount there is way less toxicity and a limit of four chemotherapeutic agents can be dispensed at each weekly treatment.
Treatments last one and half hours each week and are done in physicians office. The cost is way less than the conventional treatment. No one has died from this treatment as they have from chemotherapy.
Immunotherapy uses particular areas of your bodies immune system to fight diseases including cancer. It activates your own immune system to worker better and more accurately. It provides your immune system with elements such as man made immune proteins.
The FDA has approved several cancer immunotherapies, currently only monoclonal antibodies have been approved. Other forms are currently under study though.
Medical News Today
Alternative Treatment Center Of Southern California
American Cancer Society